Order Article Reprints

Yin S, Wang Y, Zhang B, Qu Y, Liu Y, Dai S, Zhang Y, Wang Y, Bi J. Engineered Human Heavy-Chain Ferritin with Half-Life Extension and Tumor Targeting by PAS and RGDK Peptide Functionalization. Pharmaceutics. 2021; 13(4):521. https://doi.org/10.3390/pharmaceutics13040521

Yin, Shuang, Yan Wang, Bingyang Zhang, Yiran Qu, Yongdong Liu, Sheng Dai, Yao Zhang, Yingli Wang, and Jingxiu Bi. 2021. "Engineered Human Heavy-Chain Ferritin with Half-Life Extension and Tumor Targeting by PAS and RGDK Peptide Functionalization" Pharmaceutics 13, no. 4: 521. https://doi.org/10.3390/pharmaceutics13040521

Yin, S., Wang, Y., Zhang, B., Qu, Y., Liu, Y., Dai, S., Zhang, Y., Wang, Y., & Bi, J. (2021). Engineered Human Heavy-Chain Ferritin with Half-Life Extension and Tumor Targeting by PAS and RGDK Peptide Functionalization. Pharmaceutics, 13(4), 521. https://doi.org/10.3390/pharmaceutics13040521